12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Sat, 02 May 2026 17:37:51 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Set-Cookie: UpalLiveSession=eyJpdiI6InlMM1wvYzljWm9vSHZMZmU0anJ5eTB3PT0iLCJ2YWx1ZSI6IldlV3FUMVwvVlp4VGpXd1FIK2VmYk9rSEZZeDdoM2tseGpwK3NQK1lDdzM3aGhcL0V0SUF0K1pldGN5b0lrY2hKRjFWT212SUJBMnAwV0tRTUFWZ0VHUXc9PSIsIm1hYyI6ImE3YzA0MTg2YTBiNjYzMzk0NmZkM2I1MTE3ODIyN2RkOGJiYTMyYTQyMGNiM2NlYzA0ZmFkZTJlZDEzMzI4ZDQifQ%3D%3D; expires=Tue, 01-May-2029 17:37:51 GMT; Max-Age=94608000; path=/; HttpOnly [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Sun, 03 May 2026 17:37:51 GMT [17] => vary: Accept-Encoding [18] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=Ksu4XtcfPTi5KJ4%2B2mDwt3LVW2b8JlrhVIe23HFOiL4x78EFLTxLEQH3DzoQdka4X3MXnnUHH6Gd8HmRNZ9b8%2FS4sY1qkGevhP8dnNPgopTtdvvl6ost1Z8Fo5SZV4qd2mE%3D"}]} [19] => cf-cache-status: DYNAMIC [20] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [21] => Speculation-Rules: "/cdn-cgi/speculation" [22] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [23] => Server-Timing: cfEdge;dur=6,cfOrigin;dur=133 [24] => CF-RAY: 9f58cbd6d932fd3d-SIN [25] => alt-svc: h3=":443"; ma=86400 ) 789

美国食品和药品管理局（FDA）已开始允许全美各地医生使用新冠肺炎康复者所捐赠的血浆来治疗肺炎重症患者。

有专家认为，研发有效疫苗需要最少数月时间，所以对于新型冠状病毒而言，血浆治疗可能是近期最大的治疗希望。

而纽约州州长科莫早前亦宣布，纽约州将进行血浆疗法试验，将利用新冠肺炎康复者的血浆来治疗其他确诊患者。如此，纽约州将会是美国首个进行血浆治疗试验的州。

华盛顿大学医学院医学与分子微生物学副教授亨德森博士说：“这种方法肯定有其优点，其非凡之处在于血浆治疗已有100多年历史，过往都曾经有医生透过血浆治疗其他病症患者。

不过到底血浆治疗是否有效，还需透过临床实验研究及病例报告方才知晓。但基于用血浆治疗过往的战绩，我认为它很有可能会有效治疗新冠肺炎。”

---

// // // //